[Role of catecholamines in the glucose absorption regulation in the small intestine].
During the experiments in vivo at white laboratory rats-males Wistar was established that the epinephrine and norepinephrine depending on the dosation causes the stimulation or inhibition of frequency of glucose absorption in the small intestine. The stimulating effect of epinephrine is mediated beta-, inhibitory--as alpha 1- and alpha 2-adrenoreceptors; the potentive effect of norepinephrine--by alpha-, inhibitory--alpha 1--adrenoreceprors. It was found out the personal physiological role of dopamine as inhibitory mediator for absorption of glucose in the small intestine.
Sheptitskiĭ
V A
VA
Institute of Physiology and Sanocreatology of the Moldav. Acad. Sci., Kishinev.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000502:physiology*; D004298:Dopamine / Q000502:physiology; D004837:Epinephrine / Q000502:physiology; D005947:Glucose / Q000378:metabolism*; D066298:In Vitro Techniques; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009638:Norepinephrine / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D011941:Receptors, Adrenergic / Q000502:physiology; D011954:Receptors, Dopamine / Q000502:physiology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011941:Receptors, Adrenergic; D011954:Receptors, Dopamine; D005947:Glucose; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine